EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -2.224
March 31, 2026 -1.329
December 31, 2025 -1.274
September 30, 2025 -1.309
June 30, 2025 -1.452
March 31, 2025 -3.257
December 31, 2024 -3.385
September 30, 2024 -3.599
June 30, 2024 -3.814
March 31, 2024 -3.349
December 31, 2023 -3.603
September 30, 2023 -3.596
June 30, 2023 -3.698
March 31, 2023 -3.766
December 31, 2022 -3.859
September 30, 2022 -4.031
June 30, 2022 -3.958
March 31, 2022 -3.701
December 31, 2021 -3.345
September 30, 2021 -3.147
Date Value
June 30, 2021 -2.854
March 31, 2021 -2.711
December 31, 2020 -2.787
September 30, 2020 -3.759
June 30, 2020 -4.174
March 31, 2020 -4.421
December 31, 2019 -4.496
September 30, 2019 -3.989
June 30, 2019 -3.776
March 31, 2019 -3.498
December 31, 2018 -3.185
September 30, 2018 -2.624
June 30, 2018 -2.502
March 31, 2018 -2.381
December 31, 2017 -2.292
September 30, 2017 -2.168
June 30, 2017 -1.546
March 31, 2017 -1.023
December 31, 2016 -0.4947

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Intellia Therapeutics, Inc. -3.357
Beam Therapeutics, Inc. -0.86
Prime Medicine, Inc. -1.086
Absci Corp. -0.8004
10X Genomics, Inc. -0.5898